Pages that link to "Q36817618"

The following pages link to Blocking the interaction between apolipoprotein E and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration (Q36817618):

Displaying 27 items.

• Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain (Q24308258) (← links)
• Human APOE genotype affects intraneuronal Aβ1-42 accumulation in a lentiviral gene transfer model (Q24338827) (← links)
• Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K( ) current inhibition mediated by activation of caspases and GSK-3. (Q27307787) (← links)
• Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice. (Q34240270) (← links)
• Modulation of amyloid precursor protein expression reduces β-amyloid deposition in a mouse model. (Q34584517) (← links)
• Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms (Q34628212) (← links)
• CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease? (Q35115904) (← links)
• Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis (Q35327172) (← links)
• Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer's disease (Q35772537) (← links)
• Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo (Q36271462) (← links)
• APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice (Q37615879) (← links)
• Convergence of synapses, endosomes, and prions in the biology of neurodegenerative diseases (Q38168833) (← links)
• β-Amyloid peptides and amyloid plaques in Alzheimer's disease (Q38265124) (← links)
• Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence (Q38407177) (← links)
• Alzheimer's disease: experimental models and reality (Q39057135) (← links)
• 1MeTIQ provides protection against Aβ-induced reduction of surface expression of synaptic proteins and inhibits H₂O₂-induced oxidative stress in primary hippocampal neurons. (Q40003927) (← links)
• Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer's disease pathology in TgSwDI and 3xTg mouse models (Q41846962) (← links)
• Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology (Q42008541) (← links)
• Intracellular accumulation of amyloid-β (Aβ) protein plays a major role in Aβ-induced alterations of glutamatergic synaptic transmission and plasticity. (Q42465835) (← links)
• APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis (Q56999989) (← links)
• Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease (Q57816569) (← links)
• Advances in developing novel therapeutic strategies for Alzheimer's disease (Q60045502) (← links)
• The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives (Q60933253) (← links)
• Endo-lysosomal dysregulations and late-onset Alzheimer's disease: impact of genetic risk factors. (Q64901063) (← links)
• Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease (Q89470931) (← links)
• Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk (Q89596058) (← links)
• Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies (Q92322562) (← links)